Literature DB >> 1619388

The role of apolipoprotein E genetic variants in lipoprotein disorders.

S C Rall1, R W Mahley.   

Abstract

Apolipoprotein E plays a central role in lipoprotein metabolism by serving as a ligand for the binding of lipoproteins to lipoprotein receptors. Both common and rare variants of apoE have been described. The common variants apoE2 and apoE4 have a significant impact on interindividual variation of lipid and lipoprotein levels in normal subjects. The common variant apoE2 and more than half a dozen rare variants are defective in binding to the low-density lipoprotein (LDL) receptor, and all are causally associated with the lipid disorder type III hyperlipoproteinaemia (HLP). The mode of inheritance of the disorder can be either dominant or recessive, depending on the particular mutation(s) in apoE, although the mechanisms involved are not fully understood. The common variant apoE4 and other rare variants have been reported to be associated with a variety of other lipoprotein disorders, but a causal link has not been established.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1619388     DOI: 10.1111/j.1365-2796.1992.tb01254.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  21 in total

1.  Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice.

Authors:  K Tsukamoto; P Smith; J M Glick; D J Rader
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

2.  Effect of apolipoprotein E gene Hha I restricting fragment length polymorphism on serum lipids in cholecystolithiasis.

Authors:  Qi-Yuan Lin; Jing-Ping Du; Ming-Yi Zhang; Yu-Gwei Yao; Lin Li; Nan-Sheng Cheng; Lu-Nan Yan; Lu-Jia Xiao
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

3.  Conformational flexibility in the apolipoprotein E amino-terminal domain structure determined from three new crystal forms: implications for lipid binding.

Authors:  B W Segelke; M Forstner; M Knapp; S D Trakhanov; S Parkin; Y M Newhouse; H D Bellamy; K H Weisgraber; B Rupp
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

4.  Molecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4.

Authors:  Alexander M Vezeridis; Konstantinos Drosatos; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2010-09-22       Impact factor: 5.922

5.  ApoE gene polymorphism and its relationship with coronary artery disease in ethnic Kashmiri population.

Authors:  Dil Afroze; Adfar Yousuf; Nisar A Tramboo; Zaffar A Shah; Asrar Ahmad
Journal:  Clin Exp Med       Date:  2015-09-26       Impact factor: 3.984

Review 6.  The key role of apolipoprotein E in atherosclerosis.

Authors:  Kirsty Greenow; Nigel J Pearce; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2005-04-13       Impact factor: 4.599

7.  apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL.

Authors:  Panagiotis Fotakis; Alexander Vezeridis; Ioannis Dafnis; Angeliki Chroni; Dimitris Kardassis; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2014-04-28       Impact factor: 5.922

8.  High density GWAS for LDL cholesterol in African Americans using electronic medical records reveals a strong protective variant in APOE.

Authors:  Laura J Rasmussen-Torvik; Jennifer A Pacheco; Russell A Wilke; William K Thompson; Marylyn D Ritchie; Abel N Kho; Arun Muthalagu; M Geoff Hayes; Loren L Armstrong; Douglas A Scheftner; John T Wilkins; Rebecca L Zuvich; David Crosslin; Dan M Roden; Joshua C Denny; Gail P Jarvik; Christopher S Carlson; Iftikhar J Kullo; Suzette J Bielinski; Catherine A McCarty; Rongling Li; Teri A Manolio; Dana C Crawford; Rex L Chisholm
Journal:  Clin Transl Sci       Date:  2012-08-23       Impact factor: 4.689

9.  Prevalence of the apolipoprotein E Arg145Cys dyslipidemia at-risk polymorphism in African-derived populations.

Authors:  Maen D Abou Ziki; Yael Strulovici-Barel; Neil R Hackett; Juan L Rodriguez-Flores; Jason G Mezey; Jacqueline Salit; Sharon Radisch; Charleen Hollmann; Lotfi Chouchane; Joel Malek; Mahmoud A Zirie; Amin Jayyuosi; Antonio M Gotto; Ronald G Crystal
Journal:  Am J Cardiol       Date:  2013-10-03       Impact factor: 2.778

10.  The number of cysteine residues per mole in apolipoprotein E affects systematically synchronous neural interactions in women's healthy brains.

Authors:  Arthur C Leuthold; Margaret Y Mahan; John J Stanwyck; Angeliki Georgopoulos; Apostolos P Georgopoulos
Journal:  Exp Brain Res       Date:  2013-03-17       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.